These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 18852930)

  • 1. Para-[(123)I]iodo-L-phenylalanine in patients with pancreatic adenocarcinoma: tumour uptake, whole-body kinetics, dosimetry.
    Hellwig D; Gouverneur E; Schaefer A; Raedle J; Menges M; Kirsch CM; Samnick S
    Nuklearmedizin; 2008; 47(5):220-4. PubMed ID: 18852930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p-[123I]iodo-L-phenylalanine for detection of pancreatic cancer: basic investigations of the uptake characteristics in primary human pancreatic tumour cells and evaluation in in vivo models of human pancreatic adenocarcinoma.
    Samnick S; Romeike BF; Kubuschok B; Hellwig D; Amon M; Feiden W; Menger MD; Kirsch CM
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):532-41. PubMed ID: 14722685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models.
    Hellwig D; Menges M; Schneider G; Moellers MO; Romeike BF; Menger MD; Kirsch CM; Samnick S
    Nucl Med Biol; 2005 Feb; 32(2):137-45. PubMed ID: 15721759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial evaluation of the feasibility of single photon emission tomography with p-[123 I]iodo-L-phenylalanine for routine brain tumour imaging.
    Samnick S; Hellwig D; Bader JB; Romeike BF; Moringlane JR; Feiden W; Kirsch CM
    Nucl Med Commun; 2002 Feb; 23(2):121-30. PubMed ID: 11891465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma.
    Li S; Peck-Radosavljevic M; Kienast O; Preitfellner J; Havlik E; Schima W; Traub-Weidinger T; Graf S; Beheshti M; Schmid M; Angelberger P; Dudczak R
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):198-206. PubMed ID: 15499293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body kinetics and dosimetry of L-3--123I-iodo-alpha-methyltyrosine.
    Schmidt D; Langen KJ; Herzog H; Wirths J; Holschbach M; Kiwit JC; Ziemons K; Coenen HH; Müller-Gärtner H
    Eur J Nucl Med; 1997 Sep; 24(9):1162-6. PubMed ID: 9283111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.
    Virgolini I; Szilvasi I; Kurtaran A; Angelberger P; Raderer M; Havlik E; Vorbeck F; Bischof C; Leimer M; Dorner G; Kletter K; Niederle B; Scheithauer W; Smith-Jones P
    J Nucl Med; 1998 Nov; 39(11):1928-36. PubMed ID: 9829585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-individual comparison of the human biodistribution and dosimetry of the D and L isomers of 2-[123I]iodo-phenylalanine.
    Bauwens M; Keyaerts M; Lahoutte T; Kersemans K; Caveliers V; Bossuyt A; Mertens J
    Nucl Med Commun; 2007 Oct; 28(10):823-8. PubMed ID: 17728613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Endoradiotherapy with Carrier-Added 4-[(131)I]Iodo-L-Phenylalanine: Clinical Proof-of-Principle in Refractory Glioma.
    Baum RP; Kluge A; Gildehaus FJ; Bronzel M; Schmidt K; Schuchardt C; Senftleben S; Samnick S
    Nucl Med Mol Imaging; 2011 Dec; 45(4):299-307. PubMed ID: 24900021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-individual comparison of p-[123I]-iodo-L-phenylalanine and L-3-[123I]-iodo-alpha-methyl-tyrosine for SPECT imaging of gliomas.
    Hellwig D; Romeike BF; Ketter R; Moringlane JR; Kirsch CM; Samnick S
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):24-31. PubMed ID: 17846769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.
    Israel I; Brandau W; Farmakis G; Samnick S
    Appl Radiat Isot; 2008 Apr; 66(4):513-22. PubMed ID: 18024046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of brain tumour imaging with p-[123I]iodo-L-phenylalanine and SPECT.
    Hellwig D; Ketter R; Romeike BF; Sell N; Schaefer A; Moringlane JR; Kirsch CM; Samnick S
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1041-9. PubMed ID: 15902439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.
    Kersemans V; Cornelissen B; Kersemans K; Bauwens M; Achten E; Dierckx RA; Mertens J; Slegers G
    J Nucl Med; 2005 Mar; 46(3):532-9. PubMed ID: 15750170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.
    Kersemans V; Cornelissen B; Bacher K; Kersemans K; Thierens H; Dierckx RA; De Spiegeleer B; Slegers G; Mertens J
    J Nucl Med; 2005 Dec; 46(12):2104-11. PubMed ID: 16330577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution and dosimetry of 195mPt-cisplatin in normal volunteers. Imaging agent for single photon emission computed tomography.
    Sathekge M; Wagener J; Smith SV; Soni N; Marjanovic-Painter B; Zinn C; Van de Wiele C; D'Asseler Y; Perkins G; Zeevaart JR
    Nuklearmedizin; 2013 Dec; 52(6):222-7. PubMed ID: 24108524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 123/125I-labelled 2-iodo-L: -phenylalanine and 2-iodo-D: -phenylalanine: comparative uptake in various tumour types and biodistribution in mice.
    Kersemans V; Cornelissen B; Kersemans K; Bauwens M; Dierckx RA; De Spiegeleer B; Mertens J; Slegers G
    Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):919-27. PubMed ID: 16572305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution and dosimetry of [123I]iodo-PK 11195: a potential agent for SPET imaging of the peripheral benzodiazepine receptor.
    Versijpt J; Dumont F; Thierens H; Jansen H; De Vos F; Slegers G; Santens P; Dierckx RA; Korf J
    Eur J Nucl Med; 2000 Sep; 27(9):1326-33. PubMed ID: 11007514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine.
    Kersemans V; Cornelissen B; Kersemans K; Dierckx RA; De Spiegeleer B; Mertens J; Slegers G
    Nucl Med Biol; 2006 Jan; 33(1):111-7. PubMed ID: 16459266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans.
    Lahorte CM; van de Wiele C; Bacher K; van den Bossche B; Thierens H; van Belle S; Slegers G; Dierckx RA
    Nucl Med Commun; 2003 Aug; 24(8):871-80. PubMed ID: 12869819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide receptor scintigraphy.
    Virgolini I; Kurtaran A; Raderer M; Leimer M; Angelberger P; Havlik E; Li S; Scheithauer W; Niederle B; Valent P
    J Nucl Med; 1995 Oct; 36(10):1732-9. PubMed ID: 7562036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.